WHO Advisory Committee "AZ Vaccine Has Enormous Potential to Reduce Death"

Vaccine experts from the World Health Organization and WHO gave a positive evaluation of the AstraZeneca vaccine on the 19th local time.

The WHO Vaccine Safety Advisory Committee, the COVID-19 subcommittee of GACVS, said in a statement that the AstraZeneca vaccine continues to receive positive reviews in risk-benefit analysis. "It has tremendous potential to prevent infection and reduce deaths worldwide. "I said.

The subcommittee said, "The available data do not suggest an overall increase in thrombotic diseases such as deep vein thrombosis or pulmonary embolism after corona vaccine administration."

"The reported incidence of thromboembolism after vaccination is close to the expected number of diagnoses for these diseases," he explained. "Both diseases occur naturally and are not uncommon."

In particular, he pointed out that "a very rare and specific thromboembolism has been reported in Europe after vaccination with AstraZeneca, combined with thrombocytopenia such as cerebral sinus thrombosis, but it is not clear if it is due to vaccination."